Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAMUSCULARStandard

OLANZAPINE

OLANZAPINE

Standard Dose
10MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview OLANZAPINE is listed in Drugs@FDA under application 219048 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient OLANZAPINE Form and strength POWDER;INTRAMUSCULAR - 10MG/VIAL Sponsor OMNIVIUM PHARMS Submission history Latest submission status date: 2026-01-23 00:00:00.

Structured Monograph

Clinical summary

Approval overview OLANZAPINE is listed in Drugs@FDA under application 219048 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient OLANZAPINE Form and strength POWDER;INTRAMUSCULAR - 10MG/VIAL Sponsor OMNIVIUM PHARMS Submission history Latest submission status date: 2026-01-23 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.